Evidence map›Paper›PMID 39572564›Full record

ArticleNature communications2024

A green solvent enables precursor phase engineering of stable formamidinium lead triiodide perovskite solar cells.

Benjamin M Gallant, Philippe Holzhey, Joel A Smith, Saqlain Choudhary, Karim A Elmestekawy, Pietro Caprioglio, Igal Levine, Alexandra A Sheader, Esther Y-H Hung, Fengning Yang and 9 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Morphology Formation Pathways in Solution-Processed Perovskite Thin Films.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Impact of Antisolvent and Gas Quenching on Wrinkling in CsACS applied materials & interfaces · 2025
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Benjamin M GallantClarendon Laboratory, Department of Physics, University of Oxford, Parks Road, Oxford, OX1 3PU, United Kingdom.
Philippe HolzheyClarendon Laboratory, Department of Physics, University of Oxford, Parks Road, Oxford, OX1 3PU, United Kingdom.
Joel A SmithClarendon Laboratory, Department of Physics, University of Oxford, Parks Road, Oxford, OX1 3PU, United Kingdom.
Saqlain ChoudharyClarendon Laboratory, Department of Physics, University of Oxford, Parks Road, Oxford, OX1 3PU, United Kingdom.
Karim A ElmestekawyClarendon Laboratory, Department of Physics, University of Oxford, Parks Road, Oxford, OX1 3PU, United Kingdom.ORCID http://orcid.org/0000-0002-7707-1611
Pietro CaprioglioClarendon Laboratory, Department of Physics, University of Oxford, Parks Road, Oxford, OX1 3PU, United Kingdom.
Igal LevineSolar Energy Division, Helmholtz-Zentrum Berlin für Materialien und Energie GmbH, Berlin, 12489, Germany.
Alexandra A SheaderClarendon Laboratory, Department of Physics, University of Oxford, Parks Road, Oxford, OX1 3PU, United Kingdom.
Esther Y-H HungClarendon Laboratory, Department of Physics, University of Oxford, Parks Road, Oxford, OX1 3PU, United Kingdom.
Fengning YangClarendon Laboratory, Department of Physics, University of Oxford, Parks Road, Oxford, OX1 3PU, United Kingdom.
Daniel T W ToolanDepartment of Materials, University of Manchester, Manchester, M13 9PL, UK.ORCID http://orcid.org/0000-0003-3228-854X
Rachel C KilbrideDepartment of Chemistry, University of Sheffield, Sheffield, S3 7HF, UK.ORCID http://orcid.org/0000-0002-3985-923X
Karl-Augustin ZainingerClarendon Laboratory, Department of Physics, University of Oxford, Parks Road, Oxford, OX1 3PU, United Kingdom.
James M BallClarendon Laboratory, Department of Physics, University of Oxford, Parks Road, Oxford, OX1 3PU, United Kingdom.
M Greyson ChristoforoClarendon Laboratory, Department of Physics, University of Oxford, Parks Road, Oxford, OX1 3PU, United Kingdom.ORCID http://orcid.org/0000-0001-5507-4179
Nakita K NoelClarendon Laboratory, Department of Physics, University of Oxford, Parks Road, Oxford, OX1 3PU, United Kingdom.ORCID http://orcid.org/0000-0002-8570-479X
Laura M HerzClarendon Laboratory, Department of Physics, University of Oxford, Parks Road, Oxford, OX1 3PU, United Kingdom.ORCID http://orcid.org/0000-0001-9621-334X
Dominik J KubickiSchool of Chemistry, University of Birmingham, B15 2TT, Birmingham, UK.ORCID http://orcid.org/0000-0002-9231-6779
Henry J SnaithClarendon Laboratory, Department of Physics, University of Oxford, Parks Road, Oxford, OX1 3PU, United Kingdom. henry.snaith@physics.ox.ac.uk.ORCID http://orcid.org/0000-0001-8511-790X

Funding

EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) EP/Y01376X/1RCUK | Engineering and Physical Sciences Research Council (EPSRC) EP/V027131/1
6 · The paper itself

Abstract

Perovskite solar cells (PSCs) offer an efficient, inexpensive alternative to current photovoltaic technologies, with the potential for manufacture via high-throughput coating methods. However, challenges for commercial-scale solution-processing of metal-halide perovskites include the use of harmful solvents, the expense of maintaining controlled atmospheric conditions, and the inherent instabilities of PSCs under operation. Here, we address these challenges by introducing a high volatility, low toxicity, biorenewable solvent system to fabricate a range of 2D perovskites, which we use as highly effective precursor phases for subsequent transformation to α-formamidinium lead triiodide (α-FAPbI

Identifiers

PMID39572564
PMCPMC11582696

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.